R&D Systems™ Recombinant Viral B18R Fc Chimera Biotinylated Protein

Catalog No.
BT8185025	25μg; Biotin

Catalog No. BT8185025 Supplier R&D Systems™ Supplier No. BT8185025

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Viral B18R Fc Chimera Biotinylated Protein is derived from HEK293. The Recombinant Viral B18R Fc Chimera Biotinylated Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P25213
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 3707577
• Molecular Weight (g/mol): Theoretical M.W.: 65kDa (unlabeled)
• Quantity: 25μg
• Source: Human embryonic kidney cell,HEK293-derived viral B18R protein, (N-terminus) MD Human IgG1 (Pro100-Lys300) IEGR Viral B18R (His20-Glu351) Accession &Num; P25213 (C-terminus)
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Endotoxin Concentration: <0.10 EU per 1μg of the protein by the LAL method.
• Common Name: B19R
• Gene Symbol: B19R
• Biological Activity: Measured by its ability to inhibit Type-I IFN-mediated anti-viral activity. Symons, J.A. et al. (1995) Cell 81:551. The ED50 for this effect, as measured by inhibition of Recombinant Human IFN-alpha 2, is typically 0.3-1.8ng/mL.
• Conjugate: Biotin
• Species: Virus
• Recombinant: Recombinant
• Expression System: Human embryonic kidney cell, HEK293-derived MD, N-terminus; Human IgG1 (Pro100-Lys300); IEGR; Viral B19R (His20-Glu351) Accession # P25213, C-terminus
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie™ Blue Staining